University of California - Los Angeles Health Sciences Oct 16 2024 UCLA and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their alliance to advance research in cancer immunotherapy and accelerate the development of curative treatments for the most difficult-to-treat cancers. The collaboration is backed by a substantial new investment from PICI, which recently committed $125 million to expand research efforts across a collaborative consortium of immuno-oncology academic